Michael Floyd - 06 Oct 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
06 Oct 2021
Transactions value $
$0
Form type
4
Filing time
08 Oct 2021, 16:34:45 UTC
Previous filing
06 Jan 2022
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +12,500 +625% 14,500 06 Oct 2021 Direct F1
transaction PCSA Common Stock Tax liability $0 -4,663 -33% $0 9,387 06 Oct 2021 Direct
holding PCSA Common Stock 117,409 06 Oct 2021 by Elion Oncology, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of restricted stock.